![Tom Holgate](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Holgate
Direktor/Vorstandsmitglied bei
BenevolentAI Cambridge Ltd.
Profil
Tom Joseph Charles Holgate is currently a Director at BenevolentAI Cambridge Ltd. and a Director at BenevolentAI Technology Ltd. He previously worked as a Senior Vice President & Group Finance Director at BenevolentAI SA.
Aktive Positionen von Tom Holgate
| Unternehmen | Position | Beginn |
|---|---|---|
BenevolentAI Cambridge Ltd.
 BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Direktor/Vorstandsmitglied | 21.02.2018 |
BenevolentAI Technology Ltd.
 BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Develops AI based disease agnostic drug discovery platform | Direktor/Vorstandsmitglied | 29.05.2019 |
Ehemalige bekannte Positionen von Tom Holgate
| Unternehmen | Position | Ende |
|---|---|---|
| BENEVOLENTAI S.A. | Finanzdirektor/CFO | 16.10.2024 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Commercial Services |
BenevolentAI Technology Ltd.
BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Develops AI based disease agnostic drug discovery platform | Technology Services |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
